{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T06:25:50Z","timestamp":1787120750922,"version":"build-2736575974"},"reference-count":34,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Case Reports"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Drug\u2010induced liver injury (DILI) is a leading cause of acute liver failure in the United States and remains difficult to predict and diagnose. Trimethoprim\u2010sulfamethoxazole (TMP\u2010SMX) is widely prescribed and generally well tolerated, yet rare cases of severe idiosyncratic hepatotoxicity have been reported. We describe a 30\u2010year\u2010old woman who developed fever, malaise, leukopenia, and profound hepatocellular injury days after initiating TMP\u2010SMX and neomycin for small intestinal bacterial overgrowth. TMP\u2010SMX was discontinued, and treatment with N\u2010acetylcysteine (NAC) and supportive care was initiated. Liver enzymes, coagulopathy, and renal dysfunction steadily improved, and the patient was discharged on hospital day 6 with complete resolution of laboratory abnormalities within one month. In addition to highlighting another documented case of liver injury caused by TMP\u2010SMX, this case emphasizes the unpredictable nature of drug\u2010induced hepatotoxicity, the potential use of NAC in DILI, and reinforces the importance of early recognition, comprehensive evaluation, and prompt withdrawal of the offending agent. Clinicians should maintain vigilance when new constitutional or hepatic symptoms arise during therapy and should report suspected cases to improve collective understanding and patient safety data.<\/jats:p>","DOI":"10.1002\/ccr3.72989","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:53:20Z","timestamp":1782896000000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute Liver Injury Following Outpatient Trimethoprim\u2010Sulfamethoxazole Use for Small Intestinal Bacterial Overgrowth: A Case Report"],"prefix":"10.1002","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0175-1865","authenticated-orcid":false,"given":"Kaylie","family":"Duit","sequence":"first","affiliation":[{"name":"University of Iowa  Iowa City Iowa USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7745-3860","authenticated-orcid":false,"given":"Joseph","family":"Rattenni","sequence":"additional","affiliation":[{"name":"University of Iowa  Iowa City Iowa USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauryn","family":"Hanson","sequence":"additional","affiliation":[{"name":"University of Iowa  Iowa City Iowa USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6350-2639","authenticated-orcid":false,"given":"Aaron R.","family":"Kunz","sequence":"additional","affiliation":[{"name":"University of Iowa  Iowa City Iowa USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra021844"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2007.06.001"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16146"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.03.006"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12958"},{"key":"e_1_2_12_7_1","volume-title":"ClinCalc DrugStats Database [Internet]. Version 2024.08","author":"Kane S. P.","year":"2024"},{"key":"e_1_2_12_8_1","volume-title":"WHO Model List of Essential Medicines\u201423rd List [Internet]","author":"World Health Organization","year":"2023"},{"key":"e_1_2_12_9_1","volume-title":"Bactrim (Sulfamethoxazole Trimethoprim) [Package Insert]","author":"Hoffmann\u2010La Roche Inc","year":"2013"},{"key":"e_1_2_12_10_1","volume-title":"StatPearls [Internet]","author":"Kemnic T. R.","year":"2025"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2024.1836"},{"key":"e_1_2_12_12_1","volume-title":"LiverTox: Clinical and Research Information on Drug\u2010Induced Liver Injury [Internet]","author":"National Institute of Diabetes and Digestive and Kidney Diseases","year":"2012"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.215"},{"key":"e_1_2_12_14_1","volume-title":"LiverTox: Clinical and Research Information on Drug\u2010Induced Liver Injury [Internet]","author":"National Institute of Diabetes and Digestive and Kidney Diseases","year":"2012"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23577"},{"issue":"11","key":"e_1_2_12_16_1","article-title":"Bactrim\u2010Induced Hepatotoxicity","volume":"16","author":"Onyirimba H.","year":"2024","journal-title":"Cureus"},{"issue":"10","key":"e_1_2_12_17_1","article-title":"Trimethoprim\u2010Sulfamethoxazole\u2010Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Complicated by Acute Liver Failure","volume":"14","author":"Hindosh N.","year":"2022","journal-title":"Cureus"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0000869088.10443.d9"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-021-02820-y"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.4236\/ojneph.2020.104036"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000001032"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.14309\/00000434-201710001-02238"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijn.IJN_339_16"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-19.1.56"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2013067"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.30.5.539"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1807-59322009000100014"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/1757-1626-1-44"},{"issue":"4","key":"e_1_2_12_29_1","first-page":"175","article-title":"Trimethoprim\u2010Sulfamethoxazole\u2010Associated Hepatotoxicity\u2014Part of a Hypersensitivity Syndrome","volume":"10","author":"Mainra R. R.","year":"2003","journal-title":"Canadian Journal of Clinical Pharmacology"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0012.2003.00040.x"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg8357"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.876868"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31258"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000441"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.131"}],"container-title":["Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccr3.72989","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ccr3.72989","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccr3.72989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:35:51Z","timestamp":1787117751000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccr3.72989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1002\/ccr3.72989"],"URL":"https:\/\/doi.org\/10.1002\/ccr3.72989","archive":["Portico"],"relation":{},"ISSN":["2050-0904","2050-0904"],"issn-type":[{"value":"2050-0904","type":"print"},{"value":"2050-0904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"2025-09-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e72989"}}